Liang Wang, Zhi-hui Wang, Xiao-qin Chen, Ya-jun Li, Ke-feng Wang, Yun-fei Xia and Zhong-jun Xia First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma Cancer 119
Article first published online: 18 JUL 2012 | DOI: 10.1002/cncr.27752
Extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) is a distinct subtype of natural killer cell lymphoma in which, to date, optimal treatment strategies and prognosis have not been fully defined. Combined gemcitabine, oxaliplatin, and L-asparaginase followed by involved-field radiation therapy can be an effective and feasible treatment strategy for patients with stage IE/IIE ENKTL of the upper aerodigestive tract.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field